CG Oncology (CGON) Return on Sales (2024 - 2025)
Historic Return on Sales for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to 26.24%.
- CG Oncology's Return on Sales rose 4482500.0% to 26.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 69.64%, marking a year-over-year increase of 367800.0%. This contributed to the annual value of 77.3% for FY2024, which is 1606700.0% up from last year.
- As of Q3 2025, CG Oncology's Return on Sales stood at 26.24%, which was up 4482500.0% from 232.46% recorded in Q2 2025.
- In the past 5 years, CG Oncology's Return on Sales ranged from a high of 26.24% in Q3 2025 and a low of 16551.0% during Q4 2023
- In the last 3 years, CG Oncology's Return on Sales had a median value of 201.41% in 2024 and averaged 1957.03%.
- Per our database at Business Quant, CG Oncology's Return on Sales surged by 164812500bps in 2024 and then crashed by -6306400bps in 2025.
- Quarter analysis of 3 years shows CG Oncology's Return on Sales stood at 16551.0% in 2023, then skyrocketed by 100bps to 69.75% in 2024, then surged by 62bps to 26.24% in 2025.
- Its Return on Sales stands at 26.24% for Q3 2025, versus 232.46% for Q2 2025 and 662.63% for Q1 2025.